(5-060) Reduction in Monthly Migraine Days in Patients Prescribed Galcanezumab versus Erenumab

Monday, December 5, 2022

4:15 PM – 5:15 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Psychiatry/Neurology

Co-Author(s): Mary Beth Dameron, Kristi Stice

Primary Author(s)

Amy Janowski
Pharmacy Student
University of Missouri- Kansas City School of Pharmacy, Missouri